PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial

Clinical trial NCT02382016 · COMPLETED

Trial details

NCT number: NCT02382016
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Portopulmonary Hypertension

Start date: 2015-06-23
Primary completion: 2017-10-25
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.